Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747602 · ClinicalTrials.gov registry record · Phase 1
Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production
A Phase 1 study, sponsored by Cerecin.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT02747602: Completed Phase 1 study, sponsored by Cerecin.
NCT02747602 is a Phase 1 study that has completed, run by Cerecin. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747602, a Phase 1 study, has completed, sponsored by Cerecin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To compare serum ketone body (i.e., total ketones and β-hydroxybutyrate) levels after administration of AC-1204 versus caprylic triglyceride (CT) oil, both after a standard breakfast. To evaluate the effect of a high fat diet on serum ketone body levels after administration of CT oil with a high fat breakfast versus a standard breakfast.
Interventions
- DRUG AC-1204
- DRUG caprylic triglyceride oil (standard breakfast)
- DRUG caprylic triglyceride oil (high fat breakfast)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747602
The ClinicalTrials.gov registry entry for NCT02747602 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerecin, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AC-1204 is the first listed.
NCT02747602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02747602 about?
NCT02747602 is a clinical study titled "Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production". To compare serum ketone body (i.e., total ketones and β-hydroxybutyrate) levels after administration of AC-1204 versus caprylic triglyceride (CT) oil, both after a standard breakfast. To evaluate the effect of a high fat diet on serum ketone body levels after administration of CT oil with a high fa...
What is the current status of trial NCT02747602?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2016-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02747602?
The interventions under investigation include: AC-1204 (DRUG), caprylic triglyceride oil (standard breakfast) (DRUG), caprylic triglyceride oil (high fat breakfast) (DRUG).
Who is sponsoring clinical trial NCT02747602?
This trial is sponsored by Cerecin, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.